Home > Compound List > Product Information
Ganaxolone_Molecular_structure_CAS_38398-32-2)
Click picture or here to close

Ganaxolone

Catalog No. G7795 Name Sigma Aldrich
CAS Number 38398-32-2 Website http://www.sigmaaldrich.com
M. F. C22H36O2 Telephone 1-800-521-8956
M. W. 332.52004 Fax
Purity (The product is pure based on elemental analysis, NMR, MS, optical rotation and melting point.) Email
Storage Chembase ID: 153874

SYNONYMS

IUPAC name
1-[(1S,2S,5R,7S,10R,11S,14S,15S)-5-hydroxy-2,5,15-trimethyltetracyclo[8.7.0.02,7.011,15]heptadecan-14-yl]ethan-1-one
IUPAC Traditional name
ganaxolone
Synonyms
CCD 1042
3α-Hydroxy-3β-methyl-5α-pregnan-20-one

DATABASE IDS

PubChem SID 24724496
MDL Number MFCD00945298
CAS Number 38398-32-2

PROPERTIES

MSDS Link Download
Storage Temperature 2-8°C
German water hazard class 3
Empirical Formula (Hill Notation) C22H36O2
Purity (The product is pure based on elemental analysis, NMR, MS, optical rotation and melting point.)
Purity ≥98% (HPLC)
Gene Information human ... GABRA1(2554)mouse ... Gabrg2(14406)
Apperance white solid
Solubility DMSO: ≥2 mg/mL
Solubility H2O: insoluble

DETAILS

Description (English)
Biochem/physiol Actions
Ganaxolone (3alpha-hydroxy-3beta-methyl-5alpha-pregnane-20-one) is a positive allosteric modulator of the GABAA receptor subtype; synthetic analog of the endogenous neurosteroid allopregnanolone; effective against chemically induced seizures in rats and mice. Ganaxolone is an orally active analog of allopregnanolone that is not converted to the hormonally active 3-keto form. The enhanced anticonvulsant potency of ganaxolone after neurosteroid withdrawal supports the use of ganaxolone as a specific treatment for perimenstrual catamenial epilepsy.
Description (简体中文)
Biochem/physiol Actions
Ganaxolone (3alpha-hydroxy-3beta-methyl-5alpha-pregnane-20-one) is a positive allosteric modulator of the GABAA receptor subtype; synthetic analog of the endogenous neurosteroid allopregnanolone; effective against chemically induced seizures in rats and mice. Ganaxolone is an orally active analog of allopregnanolone that is not converted to the hormonally active 3-keto form. The enhanced anticonvulsant potency of ganaxolone after neurosteroid withdrawal supports the use of ganaxolone as a specific treatment for perimenstrual catamenial epilepsy.

REFERENCES